BioSyent Inc. (TSXV: RX)
Canada
· Delayed Price · Currency is CAD
11.74
+0.10 (0.86%)
Dec 20, 2024, 3:58 PM EST
BioSyent Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 12.78 | 7.98 | 7.86 | 18.04 | 20.29 | 13.44 | Upgrade
|
Short-Term Investments | 4.28 | 18.2 | 20.83 | 10.18 | 5.29 | 8.53 | Upgrade
|
Cash & Short-Term Investments | 17.06 | 26.19 | 28.7 | 28.21 | 25.58 | 21.97 | Upgrade
|
Cash Growth | -41.74% | -8.74% | 1.72% | 10.30% | 16.40% | -10.04% | Upgrade
|
Accounts Receivable | 4.31 | 3.45 | 3.18 | 2.49 | 1.6 | 1.81 | Upgrade
|
Other Receivables | 0.03 | 0.03 | 0.32 | 0.29 | 0.22 | 0.27 | Upgrade
|
Receivables | 4.41 | 3.55 | 3.66 | 3.21 | 1.82 | 2.08 | Upgrade
|
Inventory | 5.66 | 5.89 | 4.54 | 2.2 | 2.07 | 2.14 | Upgrade
|
Prepaid Expenses | 0.39 | 0.24 | 0.25 | 0.46 | 0.31 | 0.65 | Upgrade
|
Other Current Assets | 0.02 | - | - | - | - | - | Upgrade
|
Total Current Assets | 27.55 | 35.87 | 37.14 | 34.08 | 29.77 | 26.85 | Upgrade
|
Property, Plant & Equipment | 1.22 | 1.4 | 1.61 | 1.85 | 2.07 | 2.36 | Upgrade
|
Long-Term Investments | 10.5 | 2.5 | - | - | - | - | Upgrade
|
Other Intangible Assets | 5.48 | 1.02 | 1.09 | 0.83 | 0.96 | 1.08 | Upgrade
|
Long-Term Deferred Tax Assets | 0.3 | 0.36 | 0.21 | 0.1 | 0.03 | 0.03 | Upgrade
|
Long-Term Deferred Charges | 0.27 | 0.17 | 0.17 | 0.12 | 0.13 | 0.07 | Upgrade
|
Total Assets | 45.47 | 41.53 | 40.49 | 37.17 | 33.57 | 30.97 | Upgrade
|
Accounts Payable | 6.25 | 5.08 | 5.06 | 3.56 | 3.72 | 2.92 | Upgrade
|
Current Portion of Leases | 0.19 | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | Upgrade
|
Current Income Taxes Payable | 0.25 | 0.11 | 0.32 | 0.1 | 0.25 | 0.15 | Upgrade
|
Current Unearned Revenue | 0.34 | 0.13 | 0.16 | 0.31 | 0.93 | 0.1 | Upgrade
|
Other Current Liabilities | - | 0.03 | - | - | 0.08 | 0.04 | Upgrade
|
Total Current Liabilities | 7.03 | 5.53 | 5.72 | 4.14 | 5.14 | 3.36 | Upgrade
|
Long-Term Leases | 0.89 | 1.04 | 1.22 | 1.4 | 1.56 | 1.71 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.2 | 0.2 | 0.18 | 0.08 | 0.08 | 0.1 | Upgrade
|
Total Liabilities | 8.12 | 6.77 | 7.12 | 5.61 | 6.78 | 5.17 | Upgrade
|
Common Stock | 5.14 | 5.12 | 5.37 | 5.8 | 6.39 | 7.18 | Upgrade
|
Additional Paid-In Capital | 2.15 | 2.29 | 2.23 | 1.82 | 1.49 | 1.24 | Upgrade
|
Retained Earnings | 30.26 | 27.53 | 25.91 | 24.12 | 19.08 | 17.48 | Upgrade
|
Comprehensive Income & Other | -0.2 | -0.18 | -0.14 | -0.19 | -0.17 | -0.11 | Upgrade
|
Shareholders' Equity | 37.35 | 34.76 | 33.36 | 31.55 | 26.8 | 25.79 | Upgrade
|
Total Liabilities & Equity | 45.47 | 41.53 | 40.49 | 37.17 | 33.57 | 30.97 | Upgrade
|
Total Debt | 1.08 | 1.22 | 1.4 | 1.56 | 1.71 | 1.85 | Upgrade
|
Net Cash (Debt) | 15.98 | 24.97 | 27.3 | 26.65 | 23.87 | 20.12 | Upgrade
|
Net Cash Growth | -42.98% | -8.55% | 2.42% | 11.67% | 18.63% | -17.62% | Upgrade
|
Net Cash Per Share | 1.34 | 2.05 | 2.18 | 2.07 | 1.82 | 1.44 | Upgrade
|
Filing Date Shares Outstanding | 11.59 | 11.61 | 12.1 | 12.41 | 12.74 | 13.41 | Upgrade
|
Total Common Shares Outstanding | 11.59 | 11.74 | 12.1 | 12.56 | 12.81 | 13.53 | Upgrade
|
Working Capital | 20.52 | 30.34 | 31.42 | 29.94 | 24.64 | 23.49 | Upgrade
|
Book Value Per Share | 3.22 | 2.96 | 2.76 | 2.51 | 2.09 | 1.91 | Upgrade
|
Tangible Book Value | 31.87 | 33.74 | 32.27 | 30.72 | 25.83 | 24.72 | Upgrade
|
Tangible Book Value Per Share | 2.75 | 2.87 | 2.67 | 2.45 | 2.02 | 1.83 | Upgrade
|
Machinery | 0.94 | 0.91 | 0.85 | 0.81 | 0.75 | 0.74 | Upgrade
|
Leasehold Improvements | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.